Pharmaceutical compositions containing the long pentraxin ptx3

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) A61K 38/17 (2006.01) A61K 48/00 (2006.01) C07K 14/47 (2006.01) C12N 15/10 (2006.01) C12N 15/86 (2006.01) C12P 21/02 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2315277

Pharmaceutical compositions are described containing a long pentraxin PTX3, particularly human PTX3, for the therapy of infectious and inflammatory or tumour diseases; expression vectors containing cDNA coding for PTX3; recombinant host cells transfected with such vectors; a method for producing substantial amounts of PTX3 involving the culturing of such cells, and the use of said vectors in the gene therapy of tumours.

Compositions pharmaceutiques contenant une pentraxine longue PTX3, en particulier, PTX3 humaine, servant à traiter des maladies infectieuses, inflammatoires ou tumorales; vecteurs d'expression contenant un ADNc codant pour PTX3; cellules hôtes de recombinaison transfectées par ces vecteurs; procédé servant à produire des quantités importantes de PTX3 et consistant à cultiver ces cellules et mise en application desdits vecteurs dans la thérapie génique de tumeurs.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical compositions containing the long pentraxin ptx3 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions containing the long pentraxin ptx3, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions containing the long pentraxin ptx3 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1756879

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.